A quantitative analysis of funding for pancreatic cancer research.

• DOI: 10.1200/jco.2015.33.15_suppl.4126
• Publication Date: 2019-03-07T22:21:37Z
• Authors: Andrew Eugene Hen...; Xiao Zhang; Rhonda Aizenberg; Mila McCurrach; Pat Morin; Richard Tuli; Lynn Matrisian; Lynne Davies
• Keywords: Public–private partnership

4126 Background: Although pancreatic cancer is the fourth most common cause of death, it only receives approximately 2.5% federal dollars distributed by NCI. Recognizing need for research support, patient advocacy groups, private institutions, and public institutions are working together to correct this funding gap. Methods: The International Cancer Research Partnership (ICRP) an alliance governmental charitable organizations regional, national international research. ICRP maintains a database grants awards that its members have provided. We interrogated review number their monetary value liver ( > 50% relevance) awarded from 2002 2012 in United States. In addition, we received data Pancreatic Action Network, Lustgarten Foundation, American Association Research. compared then benchmarked against cancer. Wilcoxon-Mann-Whitney test was used compare 2012. Results: Between total has increased nearly ten-fold $11 million (60 grants) $92 (347 grants). Private makes up 27% mean difference per award (public minus private) decreased $139,425 $6,396 (p < 0.001). Funding also over time period, $10.5 $59.5 million; however, contribution significantly less as (13% vs p Conclusions: 2002-2012. contributions comprise increasingly larger portion these funds. As become constrained, assumed growing role landscape helping fill